Literature DB >> 28842428

Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis.

Xiaojuan Wang1, Xiang Zhang1, Eagle S H Chu1, Xiaoting Chen2, Wei Kang3, Feng Wu1,3, Ka-Fai To3, Vincent W S Wong1, Henry L Y Chan1, Matthew T V Chan2, Joseph J Y Sung1, William K K Wu4,2, Jun Yu5.   

Abstract

Autophagic impairment is implicated in nonalcoholic fatty liver disease (NAFLD), but the molecular mechanism is unclear. We found that autophagic flux was significantly inhibited in 3 murine models of NAFLD. Interestingly, the number of acidic organelles and the level of mature cathepsin D were reduced, suggesting defective lysosome acidification. Asparagine synthetase (ASNS) was induced by endoplasmic reticulum stress, leading to the generation of asparagine, which inhibited lysosome acidification. Both steatotic- and asparagine-treated hepatocytes showed reduced lysosomal acidity and retention of lysosomal calcium. Knockdown of ASNS in steatotic hepatocytes restored autophagic flux. As a potential biomarker, increased serum p62/sequestosome 1 (SQSTM1) level was an independent risk factor for patients with steatosis and lobular inflammation. Impaired autophagy in NAFLD is elicited by defective lysosome acidification, which is caused by ASNS-induced asparagine synthesis under endoplasmic reticulum stress and subsequent retention of lysosomal calcium. p62/SQSTM1 could be used as a noninvasive biomarker in the diagnosis of NAFLD patients.-Wang, X., Zhang, X., Chu, E. S. H., Chen, X., Kang, W., Wu, F., To, K.-F., Wong, V. W. S., Chan, H. L. Y., Chan, M. T. V., Sung, J. J. Y., Wu, W. K. K., Yu, J. Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis. © FASEB.

Entities:  

Keywords:  NAFLD; asparagine synthetase; autophagy; lysosome

Mesh:

Substances:

Year:  2017        PMID: 28842428     DOI: 10.1096/fj.201601393R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.

Authors:  Huifeng Pi; Mengyu Liu; Yu Xi; Mengyan Chen; Li Tian; Jia Xie; Mingliang Chen; Zhen Wang; Min Yang; Zhengping Yu; Zhou Zhou; Feng Gao
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.

Authors:  Zishan Peng; Yingying Gong; Xuejie Wang; Weiman He; Liting Wu; Luyao Zhang; Li Xiong; Yanrui Huang; Lei Su; Peijie Shi; Xiaopei Cao; Rengyun Liu; Yanbing Li; Haipeng Xiao
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 12.910

3.  Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy-lysosomal pathway.

Authors:  Xiliang Du; Chiara Di Malta; Zhiyuan Fang; Taiyu Shen; Xiaodi Niu; Meng Chen; Bo Jin; Hao Yu; Lin Lei; Wenwen Gao; Yuxiang Song; Zhe Wang; Chuang Xu; Zhijun Cao; Guowen Liu; Xinwei Li
Journal:  Acta Pharm Sin B       Date:  2021-12-22       Impact factor: 14.903

4.  The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux.

Authors:  Xiaoting Chen; Hung Chan; Lin Zhang; Xiaodong Liu; Idy H T Ho; Xiang Zhang; Jeffery Ho; Wei Hu; Yuanyuan Tian; Shanglong Kou; Chee Sam Chan; Jun Yu; Sunny H Wong; Tony Gin; Matthew T V Chan; Xuegang Sun; William K K Wu
Journal:  J Cell Mol Med       Date:  2019-04-11       Impact factor: 5.310

Review 5.  How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Authors:  Yana Geng; Klaas Nico Faber; Vincent E de Meijer; Hans Blokzijl; Han Moshage
Journal:  Hepatol Int       Date:  2021-02-06       Impact factor: 6.047

Review 6.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

Review 7.  New Insights Into the Role of Autophagy in Liver Surgery in the Setting of Metabolic Syndrome and Related Diseases.

Authors:  Ana Isabel Álvarez-Mercado; Carlos Rojano-Alfonso; Marc Micó-Carnero; Albert Caballeria-Casals; Carmen Peralta; Araní Casillas-Ramírez
Journal:  Front Cell Dev Biol       Date:  2021-06-01

8.  Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.

Authors:  Alessandra Stacchiotti; Ilaria Grossi; Raquel García-Gómez; Gaurangkumar Arvindbhai Patel; Alessandro Salvi; Antonio Lavazza; Giuseppina De Petro; Maria Monsalve; Rita Rezzani
Journal:  Cells       Date:  2019-09-08       Impact factor: 6.600

9.  Studies of Non-Protective Autophagy Provide Evidence that Recovery from Therapy-Induced Senescence is Independent of Early Autophagy.

Authors:  Tareq Saleh; Liliya Tyutyunyk-Massey; Nipa H Patel; Emmanuel K Cudjoe; Moureq Alotaibi; David A Gewirtz
Journal:  Int J Mol Sci       Date:  2020-02-20       Impact factor: 5.923

Review 10.  Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Authors:  Patricia Rada; Águeda González-Rodríguez; Carmelo García-Monzón; Ángela M Valverde
Journal:  Cell Death Dis       Date:  2020-09-25       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.